FDA News
January 24, 2020
The FDA granted accelerated approval to tazemetostat for patients aged 16 years or older with metastatic or locally advanced epithelioid sarcoma ineligible for complete…
In the Journals
January 24, 2020
Ruxolitinib induced responses in about one-third of a cohort of patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia, according to results…
Advanced Practice
HemOnc Today, January 25, 2020
Amy Barry, MSN, RN, PPCNP-BC; Colleen Callahan, MSN, RN, CRNP; Diane Baniewicz, MSN, RN, CRNP
Chimeric antigen receptor T-cell therapy is a promising immunotherapy for children with refractory or relapsed acute lymphoblastic leukemia who otherwise have limited…
Editorial
HemOnc Today, January 25, 2020
Derek Raghavan, MD, PhD
It has been exactly 40 years since Richard M. Fox, MB, PhD, FRACP; Tatiana Jelihovsky, MBBS, DCP, FRCPA, FRCPath; and I published our paper on genetic anticipation in…